SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-22-001517
Filing Date
2022-04-22
Accepted
2022-04-22 10:54:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN FINANCIAL PRODUCTS LLC jnce_42222.htm SC 13G 25683
  Complete submission text file 0001085146-22-001517.txt   27129
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89831 | Film No.: 22844207
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 599 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE NEW YORK NY 10022 6465621000
Cowen Financial Products LLC (Filed by) CIK: 0001771015 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G